ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
This article is part of the Research TopicVolume II: Tumour microenvironment in cancer research and drug discoveryView all 5 articles
Reduced-order modeling of solute transport within physiologically realistic solid tumor microenvironment
Provisionally accepted- 1FAMU-FSU College of Engineering, Tallahassee, United States
- 2South Dakota State University, Brookings, United States
- 3Syracuse University, Syracuse, United States
- 4University of Notre Dame, Notre Dame, United States
- 5North Dakota State University, Fargo, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
ABSTRACT Introduction Solid tumors are characterized by densely packed extracellular matrices and limited vascularization, creating significant resistance to both diffusive and convective transport. Tumor growth depends on complex flow–structure interactions across multiple scales, while vascular abnormalities and enhanced permeability elevate interstitial pressure in the tumor microenvironment. Methods In this study, we developed an integrationed of numerical computationscomputational framework with a theoretical modeling framework that couples three phase, viscous-laminar, transient simulations of glycocalyx-patched tumor vessel-resolving plasma, red blood cells (RBCs), and white blood cells (WBCs) and tracking their volume fractions towith a calibrated reverse advection-diffusion (RAD) model for intratumoral plasma transport. The reduced-order tumor microenvironment model usesincorporates glycocalyx-patch on the luminal surface as an electrohydrodynamic (EHD) force at the tumor vessel wall via glycocalyx patches on the luminal surface. Akash et al. Results At the fenestra, EHD increases inlet plasma intensity relative to a non-EHD framework across all 15 numerical models (means: 0.576 non-EHD vs 0.722 EHD; gain 25.34%). Numerical simulations of plasma perfusion in both the tumor ECM domain and a microfluidic benchmark exhibit two-stage kinetics, with an initial advection-dominated regime. The RAD model reproduces this behavior and, aftera simple temporal calibration, to account for pore-scale hydrodynamic acceleration resolved by computational fluid dynamics (CFD),matches the observed propagation. Discussion By using fully resolved, EHD-inclusive multiphase CFD simulations to calibrate a reduced-order RAD model parameterized by measurable geometric features, we bridge the gap between classical Darcy–Starling tissue perfusion models and fully resolved CFD. The resulting framework provides a tractable mechanism-grounded tool for quantifying plasma progression in dense solid tumors and for establishing the baseline transport capacity of the tumor extracellular matrix, independent of solute-specific biochemical properties.
Keywords: electrohydrodynamics (EHD), Glycocalyx, Multiphase simulation, plasmaperfusion, Reduced order biomimetic modeling, Reverse advection-diffusion (RAD) model
Received: 14 Nov 2025; Accepted: 30 Jan 2026.
Copyright: © 2026 Akash, Yeasin, Mahmoudirad, Niloy, Mohammad, Reindl, Pandey and Basu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mohammad Mehedi Hasan Akash
Saikat Basu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
